Jones, Mark R.
Kaye, Alan D.
Manchikanti, Laxmaiah
Hirsch, Joshua A.
Article History
First Online: 23 February 2018
Compliance with Ethical Standards
:
: Mark R. Jones declares no conflict of interest. Alan D. Kaye is a speaker for Depomed, Inc. and Merck, Inc.; Laxmaiah Manchikanti has provided limited consulting services to Semnur Pharmaceuticals, Incorporated, which is developing non-particulate steroids. Joshua A. Hirsch is a consultant for Medtronic.
: This article does not contain any studies with human or animal subjects performed by any of the authors.